Outcomes After Liver Resection and Multidisciplinary Management of Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases Abstract #552

Introduction: Metastatic liver disease from neuroendocrine tumors (mNETs) has a significant impact on prognosis. Although complete surgical resection remains the only potentially curative therapy, a multimodal approach is becoming the standard by which it is managed.
Aim(s): To describe outcomes after liver resection (LR) of mNETs in patients with and without a multimodal approach.
Materials and methods: Retrospective analysis of patients undergoing LR for mNET at London Health Sciences Centre between 2004 and 2010.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr. Douglas Quan

To read results and conclusion, please login ...

Further abstracts you may be interested in

#530 Liver Transplantation for Metastatic Neuroendocrine Tumor: A Case Series and Proposed Selection Criteria
Introduction: Liver transplantation (LT) for neuroendocrine tumor (NET) metastases is associated with a high risk of tumor recurrence. Patient selection is the key to future success and its increased utilization.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr. Douglas Quan
Authors: Chan G, Kocha W, Reid R, Taqi A, ...
#816 Resection at Diagnosis of the Primary Pancreatic Neuroendocrine Tumor in Patients with Unresectable Liver Metastases. A Possible New Approach for a Multimodal Treatment
Introduction: Pancreatic neuroendocrine tumors (PNETs) present in more than 50% of cases with liver metastases as the only systemic localization. Liver metastases are unresectable in 80% of cases at diagnosis. In the context of metastatic disease, the benefit of primary tumor removal in terms of survival is controversial
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Surgical treatment
Presenting Author: Emilio Bertani
#1604 Resection of Liver Metastases in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Carcinomas: A Nordic Multicenter Study
Introduction: Gastroenteropancreatic neuroendocrine carcinomas (GEP-NEC) are generally characterized by synchronous metastases, high aggressiveness and a dismal prognosis. Currently, resection of liver metastases in patients with metastatic GEP-NEC is not recommended. However, the existing data are scarce.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Surgical treatment
Presenting Author: MD Renate Berget Galleberg
#1873 Meta-Analysis of Liver Resection versus Nonsurgical Treatments for Pancreatic Neuroendocrine Tumors with Liver Metastases
Introduction: Available data comparing the efficacy of different treatment regiments are rarely found. No meta-analyses have compared live resection with other nonsurgical treatments in resectable liver metastases from pNETs.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Surgical treatment
Presenting Author: Chunhui Yuan
Authors: Yuan C, ...
#3064 ALPPS for Neuroendocrine Liver Metastases Not Suitable for Conventional Hepatic Resection - Interim Analysis of the International ALPPS Registry
Introduction: Surgery is the most effective treatment option for neuroendocrine liver metastases (NELM). However, the majority of patients with NELM do not have disease that is resectable using conventional methods. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a relatively novel two-stage strategy in hepatic surgery.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Surgical treatment and Ablative Therapies
Presenting Author: Dr Ashley Clift